Blue Jet Healthcare Ltd is engaged in manufacturing of Pharma Intermediate, APIs used in Pharmaceutical and Healthcare Products. The operations of the company are organized in three product categories which are contrast media intermediates, artificial sweeteners, pharma intermediates, and active pharmaceutical ingredients.
1968
447
LTM Revenue $118M
LTM EBITDA $42.0M
$1.3B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Blue Jet Healthcare has a last 12-month revenue of $118M and a last 12-month EBITDA of $42.0M.
In the most recent fiscal year, Blue Jet Healthcare achieved revenue of $82.5M and an EBITDA of $28.8M.
Blue Jet Healthcare expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Blue Jet Healthcare valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $83.7M | $82.5M | XXX | XXX | XXX |
Gross Profit | $44.7M | $43.7M | XXX | XXX | XXX |
Gross Margin | 53% | 53% | XXX | XXX | XXX |
EBITDA | $28.2M | $28.8M | XXX | XXX | XXX |
EBITDA Margin | 34% | 35% | XXX | XXX | XXX |
Net Profit | $21.1M | $18.6M | XXX | XXX | XXX |
Net Margin | 25% | 23% | XXX | XXX | XXX |
Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Blue Jet Healthcare's stock price is INR 687 (or $8).
Blue Jet Healthcare has current market cap of INR 119B (or $1.4B), and EV of INR 115B (or $1.3B).
See Blue Jet Healthcare trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$1.3B | $1.4B | XXX | XXX | XXX | XXX | $0.19 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Blue Jet Healthcare has market cap of $1.4B and EV of $1.3B.
Blue Jet Healthcare's trades at 11.4x LTM EV/Revenue multiple, and 31.9x LTM EBITDA.
Analysts estimate Blue Jet Healthcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Blue Jet Healthcare and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $1.3B | XXX | XXX | XXX |
EV/Revenue | 12.4x | XXX | XXX | XXX |
EV/EBITDA | 35.0x | XXX | XXX | XXX |
P/E | 46.4x | XXX | XXX | XXX |
P/E/Growth | 1.7x | XXX | XXX | XXX |
EV/FCF | 707.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpBlue Jet Healthcare's NTM/LTM revenue growth is 28%
Blue Jet Healthcare's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $49K for the same period.
Over next 12 months, Blue Jet Healthcare's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Blue Jet Healthcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Blue Jet Healthcare and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | -1% | XXX | XXX | XXX | XXX |
EBITDA Margin | 36% | XXX | XXX | XXX | XXX |
EBITDA Growth | 2% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 63% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
Opex per Employee | $49K | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 3% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 26% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Jubilant Pharmova | XXX | XXX | XXX | XXX | XXX | XXX |
Biocon | XXX | XXX | XXX | XXX | XXX | XXX |
Syngene International | XXX | XXX | XXX | XXX | XXX | XXX |
Dishman Carbogen Amics | XXX | XXX | XXX | XXX | XXX | XXX |
Suven Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Blue Jet Healthcare acquired XXX companies to date.
Last acquisition by Blue Jet Healthcare was XXXXXXXX, XXXXX XXXXX XXXXXX . Blue Jet Healthcare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Blue Jet Healthcare founded? | Blue Jet Healthcare was founded in 1968. |
Where is Blue Jet Healthcare headquartered? | Blue Jet Healthcare is headquartered in India. |
How many employees does Blue Jet Healthcare have? | As of today, Blue Jet Healthcare has 447 employees. |
Is Blue Jet Healthcare publicy listed? | Yes, Blue Jet Healthcare is a public company listed on BOM. |
What is the stock symbol of Blue Jet Healthcare? | Blue Jet Healthcare trades under 544009 ticker. |
When did Blue Jet Healthcare go public? | Blue Jet Healthcare went public in 2023. |
Who are competitors of Blue Jet Healthcare? | Similar companies to Blue Jet Healthcare include e.g. Jubilant Pharmova, Biocon, Syngene International, Dishman Carbogen Amics. |
What is the current market cap of Blue Jet Healthcare? | Blue Jet Healthcare's current market cap is $1.4B |
What is the current revenue of Blue Jet Healthcare? | Blue Jet Healthcare's last 12-month revenue is $118M. |
What is the current EBITDA of Blue Jet Healthcare? | Blue Jet Healthcare's last 12-month EBITDA is $42.0M. |
What is the current EV/Revenue multiple of Blue Jet Healthcare? | Current revenue multiple of Blue Jet Healthcare is 11.4x. |
What is the current EV/EBITDA multiple of Blue Jet Healthcare? | Current EBITDA multiple of Blue Jet Healthcare is 31.9x. |
What is the current revenue growth of Blue Jet Healthcare? | Blue Jet Healthcare revenue growth between 2023 and 2024 was -1%. |
Is Blue Jet Healthcare profitable? | Yes, Blue Jet Healthcare is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.